These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Identification and study of differentially expressed miRNAs in aged NAFLD rats based on high-throughput sequencing. Zhang Y, Xiang D, Hu X, Ruan Q, Wang L, Bao Z. Ann Hepatol; 2020 Jul; 19(3):302-312. PubMed ID: 31899128 [Abstract] [Full Text] [Related]
12. Study on the action mechanism of the Polygonum perfoliatum L. on non-alcoholic fatty liver disease, based on network pharmacology and experimental validation. Liu G, Yang L, Tang Y, Lin J, Wang F, Shen J, Chang B, Kong X. J Ethnopharmacol; 2024 Jan 30; 319(Pt 3):117330. PubMed ID: 37863399 [Abstract] [Full Text] [Related]
13. Isobaric tags for relative and absolute quantitation (iTRAQ)-based proteomics for the investigation of the effect of Hugan Qingzhi on non-alcoholic fatty liver disease in rats. Yao X, Xia F, Tang W, Xiao C, Yang M, Zhou B. J Ethnopharmacol; 2018 Feb 15; 212():208-215. PubMed ID: 29031784 [Abstract] [Full Text] [Related]
15. Silencing lncRNA NEAT1 reduces nonalcoholic fatty liver fat deposition by regulating the miR-139-5p/c-Jun/SREBP-1c pathway. Jin SS, Lin CJ, Lin XF, Zheng JZ, Guan HQ. Ann Hepatol; 2022 Feb 15; 27(2):100584. PubMed ID: 34808393 [Abstract] [Full Text] [Related]
16. Roles of microRNAs in immunopathogenesis of non-alcoholic fatty liver disease revealed by integrated analysis of microRNA and mRNA expression profiles. Zhang YJ, Hu Y, Li J, Chi YJ, Jiang WW, Zhang F, Liu YL. Hepatobiliary Pancreat Dis Int; 2017 Feb 15; 16(1):65-79. PubMed ID: 28119261 [Abstract] [Full Text] [Related]
17. SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis. Shen Y, Cheng L, Xu M, Wang W, Wan Z, Xiong H, Guo W, Cai M, Xu F. Metabolism; 2023 Sep 15; 146():155657. PubMed ID: 37422021 [Abstract] [Full Text] [Related]
19. Aberrant hepatic microRNA expression in nonalcoholic fatty liver disease. Feng YY, Xu XQ, Ji CB, Shi CM, Guo XR, Fu JF. Cell Physiol Biochem; 2014 Sep 15; 34(6):1983-97. PubMed ID: 25562147 [Abstract] [Full Text] [Related]
20. Gut microbiota of miR-30a-5p-deleted mice aggravate high-fat diet-induced hepatic steatosis by regulating arachidonic acid metabolic pathway. Wang R, Zhang X, Wang Y, Lin Y, Zhou Y, Wang Y, Li G. Clin Transl Med; 2024 Oct 15; 14(10):e70035. PubMed ID: 39360667 [Abstract] [Full Text] [Related] Page: [Next] [New Search]